TLR9 Signaling and Promotes Neutrophil Adherence Through

Total Page:16

File Type:pdf, Size:1020Kb

TLR9 Signaling and Promotes Neutrophil Adherence Through Bacterial DNA Activates Endothelial Cells and Promotes Neutrophil Adherence through TLR9 Signaling This information is current as Driss El Kebir, Levente József, Wanling Pan, Lili Wang and of September 26, 2021. János G. Filep J Immunol 2009; 182:4386-4394; ; doi: 10.4049/jimmunol.0803044 http://www.jimmunol.org/content/182/7/4386 Downloaded from References This article cites 52 articles, 24 of which you can access for free at: http://www.jimmunol.org/content/182/7/4386.full#ref-list-1 http://www.jimmunol.org/ Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication by guest on September 26, 2021 *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2009 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. The Journal of Immunology Bacterial DNA Activates Endothelial Cells and Promotes Neutrophil Adherence through TLR9 Signaling1 Driss El Kebir,2 Levente Jo´zsef,2 Wanling Pan, Lili Wang, and Ja´nos G. Filep3 TLR9 detects bacterial DNA (CpG DNA) and elicits both innate and adoptive immunity. Recent evidence indicates that TLR9 is expressed in more diverse cell types than initially thought. In this study, we report that HUVECs constitutively express TLR9 and selectively recognize unmethylated CpG motifs in bacterial DNA and synthetic immune stimulatory CpG oligodeoxynucleotides. HUVECs respond to CpG DNA with rapid phosphorylation of I␬B-␣ and NF-␬B-mediated gene transcription and surface ex- pression of the adhesion molecules ICAM-1 and E-selectin independent of MAPK signaling. The telomere-derived TLR9 inhib- itory oligonucleotide 5؅-TTT AGG GTT AGG GTT AGG G-3؅, agents that block endosomal acidification such as chloroquine and bafilomycin A, and NF-␬B inhibitors abrogated CpG DNA-induced signaling. HUVEC activation by CpG DNA led to markedly enhanced neutrophil adhesion under nonstatic conditions that was further enhanced when neutrophils were stimulated with CpG Downloaded from DNA. The adhesive interactions were blocked by Abs against CD18 and, to a lesser degree, by anti-E-selectin and anti-L-selectin ␤ Abs. Our findings demonstrate that bacterial DNA promotes 2 integrin and E-selectin-mediated HUVEC-neutrophil adherence, and indicate the ability of CpG DNA to initiate and/or maintain the inflammatory response. The Journal of Immunology, 2009, 182: 4386–4394. oll-like receptors detect microbial molecular patterns and Accumulation of neutrophils at sites of infection or tissue injury http://www.jimmunol.org/ initiate innate and adoptive immune responses (1). By is a critical component of the inflammatory response. Neutrophil T eliciting potent inflammatory responses (2, 3), TLRs are recruitment is tightly regulated by coordinated expression of ad- also involved in cardiovascular diseases (4). Sustained inflamma- hesion molecules on both neutrophils and endothelial cells and tion due to chronic or recurrent infections has been linked to in- production of cytokines/chemokines (19). Accumulating evidence creased risk of cardiovascular diseases (5). TLR9, localized to in- indicates a role for bacterial DNA in the regulation of these events. tracellular compartments, recognizes viral and bacterial DNA, In mice, bacterial DNA or synthetic oligodeoxynucleotides which contains unmethylated CpG dinucleotides in certain base (ODNs)4 containing unmethylated CpG motifs promotes neutro- contexts (6, 7). Bacterial DNA (CpG DNA) released from prolif- phil accumulation at the primary sites of infection (8, 20–23). erating bacteria or following killing of bacteria may persist in tis- Consistent with enhanced neutrophil trafficking in vivo, CpG DNA by guest on September 26, 2021 sues in the absence of bacteria and participate in ongoing inflam- enhances neutrophil chemotaxis (12), induces IL-8 release (11, mation. Thus, bacterial DNA has been detected in the lung of 24), triggers L-selectin shedding and up-regulation of CD11b/ cystic fibrosis patients (8), coronary artery specimens (9), and in CD18 (Mac-1) (11, 12), and delays neutrophil apoptosis (13). the blood of critically ill patients who have had negative blood However, it is not known whether bacterial DNA could promote culture (10). The function of TLR9 in APCs has extensively been neutrophil adhesion to endothelial cells, a critical step in neutrophil studied, consistent with the role of these cells in immune surveil- trafficking into tissues. lance. TLR9 expression is, however, not restricted to APCs. For In this study, we investigated the impact of CpG DNA on neu- instance, human neutrophils (11–13), murine endothelial cells (14, trophil adherence to HUVECs. Here, we report that HUVECs con- 15), human dermal microvascular (16) and lymphatic endothelial stitutively express TLR9 and selectively recognize unmethylated cells (17), and endothelial cells of human atherosclerotic plaques CpG motifs in bacterial DNA and synthetic immune stimulatory express TLR9 (18). CpG DNA was reported to stimulate ICAM-1 CpG ODNs. CpG DNA activates HUVEC as well as neutrophils ␤ mRNA and protein expression and IL-8 release from murine en- and promotes 2 integrin and E-selectin-mediated neutrophil ad- dothelial cells (14, 15), whereas it failed to affect human lymphatic hesion, indicating its ability to initiate and/or maintain the inflam- endothelial cells (17) and even suppressed IL-8 production in hu- matory response in the absence of other bacterial constituents. man dermal microvascular endothelial cells (16). Materials and Methods Research Center, Maisonneuve-Rosemont Hospital and Department of Pathology and Bacterial and mammalian DNA Cell Biology, University of Montreal, Montreal, Quebec, Canada Escherichia coli DNA (strain B) and calf thymus DNA (Sigma-Aldrich) Received for publication September 15, 2008. Accepted for publication January were purified by extraction with phenol:chloroform:isoamyl alcohol (25: 26, 2009. 24:1, v/v/v) and ethanol precipitation. Heat-denaturated (single-stranded) The costs of publication of this article were defrayed in part by the payment of page genomic DNA was used in all experiments. For some experiments, E. coli charges. This article must therefore be hereby marked advertisement in accordance DNA was treated for 16 h at 37°C with CpG methylase SssI(2U/␮g DNA) with 18 U.S.C. Section 1734 solely to indicate this fact. in NE buffer 2 supplemented with 160 ␮M S-adenosylmethionine (New 1 This work was supported by Grant MOP-67054 (to J.G.F.) and a Doctoral Research Award (to J.L.) from the Canadian Institutes of Health Research. 2 D.E.K. and L.J. contributed equally to this work. 4 Abbreviations used in this paper: ODN, oligodeoxynucleotide; iODN, TLR9 inhib- 3 Address correspondence and reprint requests to Dr. Ja´nos G. Filep, Research Center, itory oligodeoxynucleotide; ctrlODN, control ODN. Maisonneuve-Rosemont Hospital, 5415 boulevard de l’Assomption, Montreal, Que- bec, Canada H1T 2M4. E-mail address: janos.g.fi[email protected] Copyright © 2009 by The American Association of Immunologists, Inc. 0022-1767/09/$2.00 www.jimmunol.org/cgi/doi/10.4049/jimmunol.0803044 The Journal of Immunology 4387 England Biolabs). Methylated DNA was purified as above. All DNA prep- 15-␮g nuclear extracts. Binding is expressed as OD following correction arations contained Ͻ5 ng of LPS/mg of DNA by Limulus assay. with binding to the mutant sequence GGCATAGGTCC. Phosphorylation of I␬B-␣ at Ser32 and Ser36 relative to total I␬B-␣ protein was monitored Culture of HUVECs using 20 ␮g of cytosolic protein with the CASE kit for I␬B-␣ S32/S36 (SuperArray). The amounts of phosphorylated I␬B-␣ are expressed as OD. HUVECs (cryopreserved primary cells; Cascade Biologics) were cultured in Medium 200 containing Low Serum Growth Supplement (Cascade RNase protection assay Biologics). For multiple RNase protection assays, HUVECs were lysed with 50 ␮lof TLR9 expression lysis/denaturation solution (Ambion). 32P-Labeled antisense RNA probes were generated using templates for IL-8, MCP-1, ICAM-1, E-selectin, L32, Nonpassaged primary culture of HUVECs and untreated confluent mono- and GAPDH (RiboQuant; BD Pharmingen), and the assays were performed layers of HUVECs (passages two and three) were lysed in situ. Protein with the direct protect kit (Ambion) as described previously (28). extracts were subjected to Western blotting using mouse anti-human TLR9 mAb 26C593 (Calbiochem). The results were confirmed using rat anti- Isolation and culture of neutrophils human TLR9 Ab eB72-1665 (eBioscience). In additional experiments, un- treated HUVECs were detached, permeabilized with Permeabilization Venous blood (anticoagulated with sodium heparin, 50 U/ml) was obtained Buffer (eBioscience), and stained with R-PE-conjugated anti-TLR9 Ab from healthy volunteers who had denied taking any medication for at least eB72-1665 or a class-matched irrelevant Ab (eBioscience). Fluorescence 2 wk. The Clinical Research Committee of the Maisonneuve-Rosemont was
Recommended publications
  • TLR4 and TLR9 Ligands Macrophages Induces Cross
    Lymphotoxin β Receptor Activation on Macrophages Induces Cross-Tolerance to TLR4 and TLR9 Ligands This information is current as Nadin Wimmer, Barbara Huber, Nicola Barabas, Johann of September 27, 2021. Röhrl, Klaus Pfeffer and Thomas Hehlgans J Immunol 2012; 188:3426-3433; Prepublished online 22 February 2012; doi: 10.4049/jimmunol.1103324 http://www.jimmunol.org/content/188/7/3426 Downloaded from Supplementary http://www.jimmunol.org/content/suppl/2012/02/23/jimmunol.110332 Material 4.DC1 http://www.jimmunol.org/ References This article cites 42 articles, 13 of which you can access for free at: http://www.jimmunol.org/content/188/7/3426.full#ref-list-1 Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision by guest on September 27, 2021 • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2012 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. The Journal of Immunology Lymphotoxin b Receptor Activation on Macrophages Induces Cross-Tolerance to TLR4 and TLR9 Ligands Nadin Wimmer,* Barbara Huber,* Nicola Barabas,* Johann Ro¨hrl,* Klaus Pfeffer,† and Thomas Hehlgans* Our previous studies indicated that lymphotoxin b receptor (LTbR) activation controls and downregulates inflammatory reac- tions.
    [Show full text]
  • B Cells Expression in Follicular and Marginal Zone TLR Stimulation
    TLR Stimulation Modifies BLyS Receptor Expression in Follicular and Marginal Zone B Cells This information is current as Laura S. Treml, Gianluca Carlesso, Kristen L. Hoek, Jason of October 2, 2021. E. Stadanlick, Taku Kambayashi, Richard J. Bram, Michael P. Cancro and Wasif N. Khan J Immunol 2007; 178:7531-7539; ; doi: 10.4049/jimmunol.178.12.7531 http://www.jimmunol.org/content/178/12/7531 Downloaded from References This article cites 57 articles, 25 of which you can access for free at: http://www.jimmunol.org/content/178/12/7531.full#ref-list-1 http://www.jimmunol.org/ Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication by guest on October 2, 2021 *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2007 by The American Association of Immunologists All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. The Journal of Immunology TLR Stimulation Modifies BLyS Receptor Expression in Follicular and Marginal Zone B Cells1 Laura S. Treml,2* Gianluca Carlesso,2† Kristen L. Hoek,† Jason E. Stadanlick,* Taku Kambayashi,* Richard J.
    [Show full text]
  • TLR9 Gene Transcriptional Regulation of the Human
    Transcriptional Regulation of the Human TLR9 Gene Fumihiko Takeshita, Koichi Suzuki, Shin Sasaki, Norihisa Ishii, Dennis M. Klinman and Ken J. Ishii This information is current as of September 30, 2021. J Immunol 2004; 173:2552-2561; ; doi: 10.4049/jimmunol.173.4.2552 http://www.jimmunol.org/content/173/4/2552 Downloaded from References This article cites 49 articles, 31 of which you can access for free at: http://www.jimmunol.org/content/173/4/2552.full#ref-list-1 Why The JI? Submit online. http://www.jimmunol.org/ • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication *average by guest on September 30, 2021 Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2004 by The American Association of Immunologists All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. The Journal of Immunology Transcriptional Regulation of the Human TLR9 Gene1 Fumihiko Takeshita,2* Koichi Suzuki,† Shin Sasaki,‡ Norihisa Ishii,‡ Dennis M. Klinman,* and Ken J. Ishii3* To clarify the molecular basis of human TLR9 (hTLR9) gene expression, the activity of the hTLR9 gene promoter was charac- terized using the human myeloma cell line RPMI 8226.
    [Show full text]
  • Combined Carriership of TLR9 -1237C and CD14 -260T Alleles Enhances the Risk of Developing Chronic Relapsing Pouchitis
    CORE Metadata, citation and similar papers at core.ac.uk Provided by DSpace at VU PO Box 2345, Beijing 100023, China World J Gastroenterol 2005;11(46):7323-7329 www.wjgnet.com World Journal of Gastroenterology ISSN 1007-9327 [email protected] © 2005 The WJG Press and Elsevier Inc. All rights reserved. ELSEVIER • RAPID COMMUNICATION • Combined carriership of TLR9 -1237C and CD14 -260T alleles enhances the risk of developing chronic relapsing pouchitis KM Lammers, S Ouburg, SA Morré, JBA Crusius, P Gionchetti, F Rizzello, C Morselli, E Caramelli, R Conte, G Poggioli, M Campieri, AS Peña KM Lammers, P Gionchetti, F Rizzello, C Morselli, M CONCLUSION: There is no evidence that the SNPs Campieri, Department of Internal Medicine and Gastroenterology, predispose to the need for IPAA surgery. The signifi cant Policlinico S. Orsola, University of Bologna, Bologna, Italy increase of the combined carriership of the CD14 S Ouburg, SA Morré, JBA Crusius, AS Peña, Laboratory of -260T and TLR9 -1237C alleles in the chronic relapsing Immunogenetics, VU University Medical Center, Amsterdam, The pouchitis group suggests that these markers identify Netherlands a subgroup of IPAA patients with a risk of developing E Caramelli, Institute of Histology and General Embryology, University of Bologna, Bologna, Italy chronic or refractory pouchitis. R Conte, Department of Immunohaematology and Blood Transfusion, Policlinico S. Orsola, University of Bologna, © 2005 The WJG Press and Elsevier Inc. All rights reserved. Bologna, Italy AS Peña, Laboratory of Immunogenetics and Department of Key words: Pouchitis; Innate immunity; Single nucleotide Gastroenterology, VU University Medical Center, Amsterdam, polymorphisms; CD14 ; TLR9 The Netherlands G Poggioli, Department of Surgery and Organ Transplantation, Lammers KM, Ouburg S, Morré SA, Crusius JBA, Gionchetti Policlinic S.
    [Show full text]
  • Human TLR1-9 Agonist Kit Set of Known Agonists for Human TLR1 to TLR9 Catalog Code: Tlrl-Kit1hw
    Human TLR1-9 Agonist Kit Set of known agonists for human TLR1 to TLR9 Catalog code: tlrl-kit1hw https://www.invivogen.com/human-tlr1-9-agonist-kit For research use only Version 19B14-MM PRODUCT INFORMATION • Poly(I:C) HMW and Poly(I:C) LMW - TLR3 agonists Contents Poly(I:C) is a synthetic analog of double-stranded RNA (dsRNA), • TLR1/2 agonist - Pam3CSK4 (10 µg) a molecular pattern associated with viral infection. Poly(I:C) is • TLR2 agonist - HKLM (109 cells) composed of a strand of poly(I) annealed to a strand of poly(C). • TLR3 agonist - Poly(I:C) HMW (500 µg) The size of the strands varies. Poly(I:C) HMW has a high • TLR3 agonist - Poly(I:C) LMW (500 µg) molecular weight (average size 1.5-8 kb), whereas Poly(I:C) • TLR4 agonist - LPS-EK standard (100 µg) LMW has a low molecular weight (average size 0.2-1 kb). • TLR5 agonist - FLA-ST standard(10 µg) Poly(I:C) HMW and Poly(I:C) LMW may activate the immune • TLR6/2 agonist - FSL-1 (10 µg) system differently. dsRNA is known to induce interferons (IFNs) • TLR7 agonist - Imiquimod (25 µg) and other cytokines production. IFN induction is mediated by • TLR8 agonist - ssRNA40 (25 µg) two different pathways. The first pathway leading to NF-κB • TLR9 agonist - ODN2006 (100 µg - 12.98 nmol) activation depends on the dsRNA-responsive protein kinase • 2 x 2 ml endotoxin-free water (PKR)5, whereas the second pathway is PKR-independent and involves TLR36. Storage and stability - Products are shipped at room temperature and should be stored • LPS from E.
    [Show full text]
  • Imidazoquinolines Modulate Activation of TLR7 and TLR8 By
    Oligodeoxynucleotides Differentially Modulate Activation of TLR7 and TLR8 by Imidazoquinolines This information is current as Keith K. B. Gorden, Xiaohong Qiu, John J. L. Battiste, Paul of September 28, 2021. P. D. Wightman, John P. Vasilakos and Sefik S. Alkan J Immunol 2006; 177:8164-8170; ; doi: 10.4049/jimmunol.177.11.8164 http://www.jimmunol.org/content/177/11/8164 Downloaded from References This article cites 34 articles, 14 of which you can access for free at: http://www.jimmunol.org/content/177/11/8164.full#ref-list-1 http://www.jimmunol.org/ Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication by guest on September 28, 2021 *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2006 by The American Association of Immunologists All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. The Journal of Immunology Oligodeoxynucleotides Differentially Modulate Activation of TLR7 and TLR8 by Imidazoquinolines Keith K. B. Gorden, Xiaohong Qiu, John J. L. Battiste, Paul P. D. Wightman, John P. Vasilakos, and Sefik S. Alkan1 Among the 11 human TLRs, a subfamily TLR7, TLR8, and TLR9 display similarities in structure and endosomal localization.
    [Show full text]
  • Human TLR9 Confers Responsiveness to Bacterial DNA Via Species-Specific Cpg Motif Recognition
    Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition Stefan Bauer*†‡, Carsten J. Kirschning*†, Hans Ha¨ cker*, Vanessa Redecke*, Susanne Hausmann*, Shizuo Akira§, Hermann Wagner*, and Grayson B. Lipford*‡ *Institute for Medical Microbiology, Immunology and Hygiene, Technical University of Munich, 81675 Munich, Germany; and §Department of Host Defense, Research Institute for Microbial Diseases, Osaka University, Osaka 565-0871, Japan Communicated by Johannes van Rood, Europdonor Foundation, Leiden, The Netherlands, June 11, 2001 (received for review February 2, 2001) The Toll-like receptor (TLR) family consists of phylogenetically human TLR9 (hTLR9) is correlated with CpG-DNA respon- conserved transmembrane proteins, which function as mediators siveness in primary human cells and that transfection of either of innate immunity for recognition of pathogen-derived ligands hTLR9 or mTLR9 into nonresponsive cells reconstitutes and subsequent cell activation via the Toll͞IL-1R signal pathway. MyD88-dependent CpG-DNA responses. Transfected hTLR9 Here, we show that human TLR9 (hTLR9) expression in human and mTLR9 required distinct CpG motifs for signal initiation, immune cells correlates with responsiveness to bacterial deoxy- implying they directly engage immunostimulatory CpG-DNA in cytidylate-phosphate-deoxyguanylate (CpG)-DNA. Notably ‘‘gain a species-specific manner. of function’’ to immunostimulatory CpG-DNA is achieved by ex- pressing TLR9 in human nonresponder cells. Transfection of either Materials and Methods human or murine TLR9 conferred responsiveness in a CD14- and Cells and Reagents. Human embryonic kidney 293 cells were from MD2-independent manner, yet required species-specific CpG-DNA ATCC. Peripheral blood mononuclear cells (PBMC), human B ϩ motifs for initiation of the Toll͞IL-1R signal pathway via MyD88.
    [Show full text]
  • TLR8 Differences Between Human TLR7 and Synthetic TLR Agonists
    Synthetic TLR Agonists Reveal Functional Differences between Human TLR7 and TLR8 Keith B. Gorden, Kevin S. Gorski, Sheila J. Gibson, Ross M. Kedl, William C. Kieper, Xiaohong Qiu, Mark A. Tomai, This information is current as Sefik S. Alkan and John P. Vasilakos of September 29, 2021. J Immunol 2005; 174:1259-1268; ; doi: 10.4049/jimmunol.174.3.1259 http://www.jimmunol.org/content/174/3/1259 Downloaded from References This article cites 36 articles, 14 of which you can access for free at: http://www.jimmunol.org/content/174/3/1259.full#ref-list-1 http://www.jimmunol.org/ Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication by guest on September 29, 2021 *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2005 by The American Association of Immunologists All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. The Journal of Immunology Synthetic TLR Agonists Reveal Functional Differences between Human TLR7 and TLR8 Keith B. Gorden, Kevin S. Gorski, Sheila J. Gibson, Ross M. Kedl,1 William C.
    [Show full text]
  • TLR8 on Dendritic Cells and TLR9 on B Cells Restrain TLR7-Mediated Spontaneous Autoimmunity in C57BL/6 Mice
    TLR8 on dendritic cells and TLR9 on B cells restrain TLR7-mediated spontaneous autoimmunity in C57BL/6 mice Benoit Desnuesa,b,c,1, Amanda Beatriz Macedoa,b,c,1, Annie Roussel-Quevala,b,c, Johnny Bonnardela,b,c, Sandrine Henria,b,c, Olivier Demariaa,b,c,2, and Lena Alexopouloua,b,c,3 aCentre d’Immunologie de Marseille-Luminy, Aix-Marseille University UM 2, 13288 Marseille, France; bInstitut National de la Santé et de la Recherche Médicale, Unité Mixte de Recherche 1104, 13288 Marseille, France; and cCentre National de la Recherche Scientifique, Unité Mixte de Recherche 7280, 13288 Marseille, France Edited* by Richard A. Flavell, Yale School of Medicine, Howard Hughes Medical Institute, New Haven, CT, and approved December 18, 2013 (received for review August 5, 2013) Systemic lupus erythematosus (SLE) is a complex autoimmune endosomal localization isolate TLR3, TLR7, TLR8, and disease with diverse clinical presentations characterized by the TLR9 away from self-nucleic acids in the extracellular space, still presence of autoantibodies to nuclear components. Toll-like re- self-RNA or -DNA can become a potent trigger of cell activation ceptor (TLR)7, TLR8, and TLR9 sense microbial or endogenous nucleic when transported into TLR-containing endosomes, and such acids and are implicated in the development of SLE. In mice TLR7- recognition can result in sterile inflammation and autoimmunity, deficiency ameliorates SLE, but TLR8- or TLR9-deficiency exacerbates including SLE (4, 15, 16). The connection of the endosomal the disease because of increased TLR7 response. Thus, both TLR8 TLRs with SLE originates mainly from mouse models, where and TLR9 control TLR7 function, but whether TLR8 and TLR9 act in TLR7 signaling seems to play a central role.
    [Show full text]
  • Set of Known Multispecies TLR9 Agonists (A & C-Classes Cpg Odns)
    AS et& of kCnow-nC mulltaispsecsiese TLsR9 TagoLnisRts (9A & A C-gClaossens CipsG tO DKNs)it Catalog # tlrl-kit9ac For research use only Version # 14B07-MM PrODuct iNfOrMatiON SeQueNceS content: ODN 1585 (mouse preferred): 5’-ggGGTCAACGTTGAgggggg-3’ (20 mer) ODNs are provided lyophilized: ODN 2216 (human/mouse): 5’-ggGG GACGA:TCGTC gggggg-3’ (20 mer) • 100 µg (15.51 nmol) ODN 1585 ODN 2336 (human/mouse): 5’-gggG ACGAC:GTCGT Ggggggg-3’ (21 mer) • 100 µg (15.54 nmol) ODN 2216 ODN 2395 (human preferred): 5’-tcgtcgtttt cggcgc:gcgccg -3’ (22 mer) • 100 µg (14.75 nmol) ODN 2336 ODN M362 (human preferred): 5’-tcgt cgtcgttc:gaacgacg ttgat-3’ (25 mer) ODN D-SL03 (multispecies): 5’-tcgcgaacgttcgccgcgttcgaacgcgg-3’ (29 mer) • 100 µg (14.18 nmol) ODN 2395 Note: Bases shown in capital letters are phosphodiester and those in lower • 100 µg (12.40 nmol) ODN M362 case are phosphorothioate (nuclease resistant). Palindrome is underlined. • 100 µg (10.7 nmol) ODN D-SL03 • 1.5 ml endotoxin-free water Storage and stability: MetHODS - Products are shipped at room temperature and should be stored at -20°C. Preparation of stock solution (500 µM) - Upon resuspension, prepare aliquots of ODN and store at -20°C. - Resuspend ODN with endotoxin-free water provided. Product is stable 6 months at -20°C. Avoid repeated freeze -thaw cycles. Quality control Product Working Stock solution Volume of - TLR9 activity is tested using HEK-Blue ™ TLR9 cells. concentration concentration solvent - The absence of bacterial contamination (endotoxins, peptidoglycans) is ODN 1585 5 µM 500 µM 31 µl H 2O controlled using HEK-Blue ™ TLR2 and HEK-Blue ™ TLR4 cells.
    [Show full text]
  • Development of TLR9 Agonists for Cancer Therapy
    Development of TLR9 agonists for cancer therapy Arthur M. Krieg J Clin Invest. 2007;117(5):1184-1194. https://doi.org/10.1172/JCI31414. Review Series In vertebrates, the TLRs are a family of specialized immune receptors that induce protective immune responses when they detect highly conserved pathogen-expressed molecules. Synthetic agonists for several TLRs, including TLR3, TLR4, TLR7, TLR8, and TLR9, have been or are being developed for the treatment of cancer. TLR9 detects the unmethylated CpG dinucleotides prevalent in bacterial and viral DNA but not in vertebrate genomes. As discussed in this Review, short synthetic oligodeoxynucleotides containing these immune stimulatory CpG motifs activate TLR9 in vitro and in vivo, inducing innate and adaptive immunity, and are currently being tested in multiple phase II and phase III human clinical trials as adjuvants to cancer vaccines and in combination with conventional chemotherapy and other therapies. Find the latest version: https://jci.me/31414/pdf Review series Development of TLR9 agonists for cancer therapy Arthur M. Krieg Coley Pharmaceutical Group, Wellesley, Massachusetts, USA. In vertebrates, the TLRs are a family of specialized immune receptors that induce protective immune responses when they detect highly conserved pathogen-expressed molecules. Synthetic agonists for several TLRs, including TLR3, TLR4, TLR7, TLR8, and TLR9, have been or are being developed for the treatment of cancer. TLR9 detects the unmethylated CpG dinucleotides prevalent in bacterial and viral DNA but not in vertebrate genomes. As dis- cussed in this Review, short synthetic oligodeoxynucleotides containing these immune stimulatory CpG motifs activate TLR9 in vitro and in vivo, inducing innate and adaptive immunity, and are currently being tested in mul- tiple phase II and phase III human clinical trials as adjuvants to cancer vaccines and in combination with conven- tional chemotherapy and other therapies.
    [Show full text]
  • Stimulation of TLR2 and TLR4 Differentially Skews the Balance of T Cells in a Mouse Model of Arthritis
    Stimulation of TLR2 and TLR4 differentially skews the balance of T cells in a mouse model of arthritis Shahla Abdollahi-Roodsaz, … , Fátima Ribeiro-Dias, Wim B. van den Berg J Clin Invest. 2008;118(1):205-216. https://doi.org/10.1172/JCI32639. Research Article Autoimmunity TLRs may contribute to the progression of rheumatoid arthritis through recognition of microbial or host-derived ligands found in arthritic joints. Here, we show that TLR2 and TLR4, but not TLR9, are involved in the pathogenesis of autoimmune arthritis and play distinct roles in the regulation of T cells and cytokines. We investigated the involvement of TLR2, TLR4, and TLR9 in the progression of arthritis using IL-1 receptor antagonist–knockout (IL1rn–/–) mice, which spontaneously develop an autoimmune T cell–mediated arthritis. Spontaneous onset of arthritis was dependent on TLR activation by microbial flora, as germ-free mice did not develop arthritis. Clinical and histopathological evaluation of IL1rn–/–Tlr2–/– mice revealed more severe arthritis, characterized by reduced suppressive function of Tregs and substantially increased IFN-γ production by T cells. IL1rn–/–Tlr4–/– mice were, in contrast, protected against severe arthritis and had markedly lower numbers of Th17 cells and a reduced capacity to produce IL-17. A lack of Tlr9 did not affect the progression of arthritis. While any therapeutic intervention targeting TLR2 still seems complicated, the strict position of TLR4 upstream of a number of pathogenic cytokines including IL-17 provides an interesting potential therapeutic target for rheumatoid arthritis. Find the latest version: https://jci.me/32639/pdf Research article Stimulation of TLR2 and TLR4 differentially skews the balance of T cells in a mouse model of arthritis Shahla Abdollahi-Roodsaz,1 Leo A.B.
    [Show full text]